AIF-M1 Monoclonal Antibody

This gene encodes a flavoprotein essential for nuclear disassembly in apoptotic cells, and it is found in the mitochondrial intermembrane space in healthy cells. Induction of apoptosis results in the translocation of this protein to the nucleus where it affects chromosome condensation and fragmentation. In addition, this gene product induces mitochondria to release the apoptogenic proteins cytochrome c and caspase-9. Mutations in this gene cause combined oxidative phosphorylation deficiency 6 (COXPD6), a severe mitochondrial encephalomyopathy, as well as Cowchock syndrome, also known as X-linked recessive Charcot-Marie-Tooth disease-4 (CMTX-4), a disorder resulting in neuropathy, and axonal and motor-sensory defects with deafness and mental retardation. Alternative splicing results in multiple transcript variants. A related pseudogene has been identified on chromosome

Introducing the AIF-M1 Monoclonal Antibody, a cutting-edge biotechnological innovation designed to revolutionize the field of immunology. This meticulously crafted antibody is meticulously engineered to specifically target and bind to the Apoptosis-Inducing Factor (AIF), a crucial protein involved in programmed cell death.

The AIF-M1 Monoclonal Antibody boasts an exceptional level of specificity and affinity, ensuring unparalleled accuracy in its binding to the AIF protein. This attribute enables researchers and clinicians to confidently utilize this antibody in a wide range of applications, including immunohistochemistry, immunofluorescence, and western blotting.

With its superior performance, the AIF-M1 Monoclonal Antibody offers an invaluable tool for investigating the intricate mechanisms underlying apoptosis and its implications in various physiological and pathological processes. Its exceptional sensitivity and reliability empower scientists to delve deeper into the intricate workings of cell death, shedding light on critical pathways and potential therapeutic targets.

Furthermore, the AIF-M1 Monoclonal Antibody is meticulously manufactured using state-of-the-art techniques, ensuring batch-to-batch consistency and reproducibility. Rigorous quality control measures are implemented throughout the production process, guaranteeing the utmost reliability and accuracy in experimental results.

In summary, the AIF-M1 Monoclonal Antibody represents a groundbreaking advancement in the realm of immunology, offering researchers and clinicians an indispensable tool for unraveling the complexities of apoptosis. With its exceptional specificity, sensitivity, and reliability, this antibody is poised to revolutionize the field, facilitating groundbreaking discoveries and paving the way for novel therapeutic interventions.